NuVasive announces launch of ALIF implant and instrumentation

NuVasive announced the launch of Brigade Lateral, an interbody implant and instrumentation optimized for lateral anterior lumbar interbody fusion spine surgery.

According to a company press release, the Brigade Lateral includes improved instrumentation, a new insertion method and an expanded lordotic implant offering. The instrumentation reportedly offers surgeons a low-profile and reproducible insertion method, which can enhance surgical workflow. With a variety of lordotic implant options, the Brigade Lateral allows surgeons to customize lordosis based on a patient’s need.

“NuVasive pioneered the lateral approach in spine surgery and continues to lead the industry with disruptive procedural solutions that maximize the efficiency of these less invasive techniques while retaining the inherent benefits to surgeons, patients and hospitals,” Matt Link, president, strategy, technology and corporate development for NuVasive, said in the release. “Brigade Lateral is no exception and extends our comprehensive procedural offering to a wider range of indications from the lateral approach.”

Reference:

www.nuvasive.com

NuVasive announced the launch of Brigade Lateral, an interbody implant and instrumentation optimized for lateral anterior lumbar interbody fusion spine surgery.

According to a company press release, the Brigade Lateral includes improved instrumentation, a new insertion method and an expanded lordotic implant offering. The instrumentation reportedly offers surgeons a low-profile and reproducible insertion method, which can enhance surgical workflow. With a variety of lordotic implant options, the Brigade Lateral allows surgeons to customize lordosis based on a patient’s need.

“NuVasive pioneered the lateral approach in spine surgery and continues to lead the industry with disruptive procedural solutions that maximize the efficiency of these less invasive techniques while retaining the inherent benefits to surgeons, patients and hospitals,” Matt Link, president, strategy, technology and corporate development for NuVasive, said in the release. “Brigade Lateral is no exception and extends our comprehensive procedural offering to a wider range of indications from the lateral approach.”

Reference:

www.nuvasive.com